Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-26T23:01:44.850Z Has data issue: false hasContentIssue false
  • English
  • Français

Association of a coronavirus disease 2019 (COVID-19) vaccine booster with control of a COVID-19 outbreak in a long-term care facility in Switzerland, November to December 2021

Published online by Cambridge University Press:  13 December 2023

Thomas W. Leiblein Open the ORCID record for Thomas W. Leiblein [Opens in a new window] ,
Annemarie Winistörfer ,
Kurt Seiler ,
Rudolf Hauri  and
Rami Sommerstein Open the ORCID record for Rami Sommerstein [Opens in a new window]
Thomas W. Leiblein*
Affiliation:
Hirslanden AndreasKlinik, Cham, Zug, Switzerland
Annemarie Winistörfer
Affiliation:
Pflegezentrum Ennetsee, Cham, Zug, Switzerland
Kurt Seiler
Affiliation:
Pflegezentrum Ennetsee, Cham, Zug, Switzerland
Rudolf Hauri
Affiliation:
Directorate of Health, Office of Health, Zug, Switzerland
Rami Sommerstein
Affiliation:
Hirslanden AndreasKlinik, Cham, Zug, Switzerland Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland
*
Corresponding author: Thomas W. Leiblein; Email: tleiblein@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Coronavirus disease 2019 (COVID-19) outbreaks in long-term care facilities are often correlated with high case fatality rates. We describe the association of administration of an mRNA booster with the control of an outbreak. Our findings highlight the possibility of vaccine booster early in an outbreak as a promising method to mitigate the spread of infection.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 45 , Issue 4 , April 2024 , pp. 543 - 545
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

McMichael, TM, Currie, DW, Clark, S, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med 2020;382:2005–2011.CrossRefGoogle Scholar
Chudasama, DY, Milbourn, H, Nsonwu, O, et al. Penetration and impact of COVID-19 in long-term care facilities in England: population surveillance study. Int J Epidemiol 2021;50:1804–1813.CrossRefGoogle ScholarPubMed
Bagchi, S, Mak, J, Li, Q, et al. Rates of COVID-19 among residents and staff members in nursing homes—United States, May 25–November 22, 2020. Morb Mortal Wkly Rep 2021;70:52–55.CrossRefGoogle Scholar
Bar-On, YM, Goldberg, Y, Mandel, M, et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med 2021;385:1393–1400.CrossRefGoogle ScholarPubMed
Basta, M, Skourti, E. The impact of COVID-19 pandemic on elderly with neurocognitive disorders. Psychiatriki 2023;34:177–180.Google ScholarPubMed
Shrotri, M, Krutikov, M, Palmer, T, et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect Dis 2021;21:1529–1538.CrossRefGoogle ScholarPubMed